drugset

drugset / Trial / NCT01257958

Vitamin D Pilot Study in Patients With Multiple Sclerosis

NCT01257958 ↗

Phase 1 Completed University of Wisconsin, Madison

NaSingle-groupTreatment

Summary

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

Timeline

Start: 1998-02
Primary completion: 2000-02
Completion: 2000-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	19 nor vitamin d	Unknown	—	—

Indications